Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:16844101rdf:typepubmed:Citationlld:pubmed
pubmed-article:16844101lifeskim:mentionsumls-concept:C0016733lld:lifeskim
pubmed-article:16844101lifeskim:mentionsumls-concept:C0013036lld:lifeskim
pubmed-article:16844101lifeskim:mentionsumls-concept:C0221198lld:lifeskim
pubmed-article:16844101lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:16844101lifeskim:mentionsumls-concept:C0449243lld:lifeskim
pubmed-article:16844101lifeskim:mentionsumls-concept:C1272706lld:lifeskim
pubmed-article:16844101lifeskim:mentionsumls-concept:C1880108lld:lifeskim
pubmed-article:16844101pubmed:issue1lld:pubmed
pubmed-article:16844101pubmed:dateCreated2006-8-28lld:pubmed
pubmed-article:16844101pubmed:abstractTextBehavioral and pharmacological challenges using methamphetamine (MAP-0.5 and 1.0 mg/kg, i.p.), haloperidol (HAL-0.12 mg/kg, i.p.), and sulfated cholecystokinin octapeptide (CCK-0.05 and 0.1 mg/kg, i.p.) were used to evaluate the effects of excitotoxic lesions of cholinergic cell bodies in the medial septal area and the nucleus basalis magnocellularis, radiofrequency lesions of the fimbria-fornix, and aspiration lesions of the frontal cortex on interval timing in rats trained on a 40-s peak-interval procedure. Results demonstrated that lesions of the nucleus basalis magnocellularis and frontal cortex selectively reduced the modulatory control of clock speed which is likely mediated by dopamine D(2) receptors located on cortico-striatal neurons.lld:pubmed
pubmed-article:16844101pubmed:languageenglld:pubmed
pubmed-article:16844101pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16844101pubmed:citationSubsetIMlld:pubmed
pubmed-article:16844101pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16844101pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16844101pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16844101pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16844101pubmed:statusMEDLINElld:pubmed
pubmed-article:16844101pubmed:monthSeplld:pubmed
pubmed-article:16844101pubmed:issn0006-8993lld:pubmed
pubmed-article:16844101pubmed:authorpubmed-author:MeckWarren...lld:pubmed
pubmed-article:16844101pubmed:issnTypePrintlld:pubmed
pubmed-article:16844101pubmed:day7lld:pubmed
pubmed-article:16844101pubmed:volume1108lld:pubmed
pubmed-article:16844101pubmed:ownerNLMlld:pubmed
pubmed-article:16844101pubmed:authorsCompleteYlld:pubmed
pubmed-article:16844101pubmed:pagination157-67lld:pubmed
pubmed-article:16844101pubmed:meshHeadingpubmed-meshheading:16844101...lld:pubmed
pubmed-article:16844101pubmed:meshHeadingpubmed-meshheading:16844101...lld:pubmed
pubmed-article:16844101pubmed:meshHeadingpubmed-meshheading:16844101...lld:pubmed
pubmed-article:16844101pubmed:meshHeadingpubmed-meshheading:16844101...lld:pubmed
pubmed-article:16844101pubmed:meshHeadingpubmed-meshheading:16844101...lld:pubmed
pubmed-article:16844101pubmed:meshHeadingpubmed-meshheading:16844101...lld:pubmed
pubmed-article:16844101pubmed:meshHeadingpubmed-meshheading:16844101...lld:pubmed
pubmed-article:16844101pubmed:meshHeadingpubmed-meshheading:16844101...lld:pubmed
pubmed-article:16844101pubmed:meshHeadingpubmed-meshheading:16844101...lld:pubmed
pubmed-article:16844101pubmed:meshHeadingpubmed-meshheading:16844101...lld:pubmed
pubmed-article:16844101pubmed:meshHeadingpubmed-meshheading:16844101...lld:pubmed
pubmed-article:16844101pubmed:meshHeadingpubmed-meshheading:16844101...lld:pubmed
pubmed-article:16844101pubmed:meshHeadingpubmed-meshheading:16844101...lld:pubmed
pubmed-article:16844101pubmed:meshHeadingpubmed-meshheading:16844101...lld:pubmed
pubmed-article:16844101pubmed:meshHeadingpubmed-meshheading:16844101...lld:pubmed
pubmed-article:16844101pubmed:meshHeadingpubmed-meshheading:16844101...lld:pubmed
pubmed-article:16844101pubmed:year2006lld:pubmed
pubmed-article:16844101pubmed:articleTitleFrontal cortex lesions eliminate the clock speed effect of dopaminergic drugs on interval timing.lld:pubmed
pubmed-article:16844101pubmed:affiliationDepartment of Psychology and Neuroscience, Duke University, 572 Research Drive, Genome Sciences Research Building II-Box 91050, Durham, NC 27708-0086, USA. meck@psych.duke.edulld:pubmed
pubmed-article:16844101pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:16844101pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16844101lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16844101lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16844101lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16844101lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16844101lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16844101lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16844101lld:pubmed